Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model

Human Molecular Genetics

Volumn 23, Issue 23, 2014, Pages 6286-6301

  Guedes, Joana R ^a,b   Custódia, Carlos M ^c   Silva, Ricardo J ^c   de Almeida, Luís P ^a,d   de Lima, Maria C Pedroso ^a,c   Cardoso, Ana L ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA INTERFERON; INTERLEUKIN 6; MICRORNA 155; OLIGOMER; PROTEIN C JUN; SUPPRESSOR OF CYTOKINE SIGNALING 1; MICRORNA; MIRN155 MICRORNA, MOUSE; SOCS1 PROTEIN, MOUSE; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; GLIOSIS; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; CELL LINE; IMMUNOLOGY; INFLAMMATION; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALIA; MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; BRAIN; CELL LINE; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MICRORNAS; NEURONS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 84926341070     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu348     Document Type: Article

References (68)

1. El Khoury, J. and Luster, A.D. (2008) Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol. Sci., 29, 626-632.
2. Dheen, S.T., Jun, Y., Yan, Z., Tay, S.S. and Ling, E.A. (2005) Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia, 50, 21-31.
3. Lucin, K.M. and Wyss-Coray, T. (2009) Immune activation in brain aging and neurodegeneration: too much or too little? Neuron, 64, 110-122.
4. Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C. and Gage, F.H. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell, 140, 918-934.
5. El Khoury, J., Toft, M., Hickman, S.E., Means, T.K., Terada, K., Geula, C. and Luster, A.D. (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med., 13, 432-438.
6. Wyss-Coray, T., Loike, J.D., Brionne, T.C., Lu, E., Anankov, R., Yan, F., Silverstein, S.C. and Husemann, J. (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med., 9, 453-457.
7. D'Andrea, M.R., Cole, G.M. and Ard, M.D. (2004) The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol. Aging, 25, 675-683.
8. Griffin, W.S., Sheng, J.G., Royston, M.C., Gentleman, S.M., McKenzie, J.E., Graham, D.I., Roberts, G.W. and Mrak, R.E. (1998) Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol., 8, 65-72.
9. Parachikova, A., Agadjanyan, M.G., Cribbs, D.H., Blurton-Jones, M., Perreau, V., Rogers, J., Beach, T.G. and Cotman, C.W. (2007) Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging, 28, 1821-1833.
10. Saijo, K., Winner, B., Carson, C.T., Collier, J.G., Boyer, L., Rosenfeld, M.G., Gage, F.H. and Glass, C.K. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell, 137, 47-59.
11. Agulhon, C., Sun, M.Y., Murphy, T., Myers, T., Lauderdale, K. and Fiacco, T.A. (2012) Calcium Signaling and Gliotransmission in Normal versus Reactive Astrocytes. Front. Pharmacol., 3, 139.
12. Heneka, M.T. and O'Banion, M.K. (2007) Inflammatory processes in Alzheimer's disease. J. Neuroimmunol., 184, 69-91.
13. Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schuffer, W. et al. (2007) Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol. Biochem., 20, 947-956.
14. Letiembre, M., Liu, Y., Walter, S., Hao, W., Pfander, T., Wrede, A., Schulz-Schaeffer, W. and Fassbender, K. (2009) Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging, 30, 759-768.
15. Stewart, C.R., Stuart, L.M., Wilkinson, K., van Gils, J.M., Deng, J., Halle, A., Rayner, K.J., Boyer, L., Zhong, R., Frazier, W.A. et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol., 11, 155-161.
16. Gorina, R., Font-Nieves, M., Marquez-Kisinousky, L., Santalucia, T. and Planas, A.M. (2011) Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1/Stat1 pathways. Glia, 59, 242-255.
17. Tang, S.C., Lathia, J.D., Selvaraj, P.K., Jo, D.G., Mughal, M.R., Cheng, A., Siler, D.A., Markesbery, W.R., Arumugam, T.V. and Mattson, M.P. (2008) Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol., 213, 114-121.
18. Bernardi, A., Frozza, R.L., Meneghetti, A., Hoppe, J.B., Battastini, A.M., Pohlmann, A.R., Guterres, S.S. and Salbego, C.G. (2012) Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Abeta1-42 in Alzheimer's disease models. Int. J. Nanomed., 7, 4927-4942.
19. Vukic, V., Callaghan, D., Walker, D., Lue, L.F., Liu, Q.Y., Couraud, P.O., Romero, I.A., Weksler, B., Stanimirovic, D.B. and Zhang, W. (2009) Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol. Dis., 34, 95-106.
20. Cardoso, A.L., Costa, P., de Almeida, L.P., Simoes, S., Plesnila, N., Culmsee, C., Wagner, E. and de Lima, M.C. (2010) Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo. J. Control. Release, 142, 392-403.
21. Lukiw, W.J., Zhao, Y. and Cui, J.G. (2008) An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem., 283, 31315-31322.
22. Cogswell, J.P., Ward, J., Taylor, I.A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C. et al. (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis., 14, 27-41.
23. Li, Y.Y., Cui, J.G., Dua, P., Pogue, A.I., Bhattacharjee, S. and Lukiw, W.J. (2011) Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci. Lett., 499, 109-113.
24. Thai, T.H., Calado, D.P., Casola, S., Ansel, K.M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J.L. et al. (2007) Regulation of the germinal center response by microRNA-155. Science, 316, 604-608.
25. Cardoso, A.L., Guedes, J.R., Pereira de Almeida, L. and Pedroso de Lima, M.C. (2012) miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology, 135, 73-88.
26. Guedes, J., Cardoso, A.L. and Pedroso de Lima, M.C. (2013) Involvement of microRNA in microglia-mediated immune response. Clin. Dev. Immunol., 2013, 186872.
27. O'Connell, R.M., Taganov, K.D., Boldin, M.P., Cheng, G. and Baltimore, D. (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA, 104, 1604-1609.
28. Onyeagucha, B.C., Mercado-Pimentel, M.E., Hutchison, J., Flemington, E.K. and Nelson, M.A. (2013) S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Exp. Cell Res., 319, 2081-2090.
29. Mor, E., Cabilly, Y., Goldshmit, Y., Zalts, H., Modai, S., Edry, L., Elroy-Stein, O. and Shomron, N. (2011) Species-specific microRNA roles elucidated following astrocyte activation. Nucleic Acids Res., 39, 3710-3723.
30. Tarassishin, L., Bauman, A., Suh, H.S. and Lee, S.C. (2012) Anti-viral and anti-inflammatory mechanisms of the innate immune transcription factor interferon regulatory factor 3: relevance to human CNS diseases. J. Neuroimmune Pharmacol., 8, 132-144.
31. McGeer, E.G. and McGeer, P.L. (2003) Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 741-749.
32. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B.P. and LaFerla, F.M. (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging, 24, 1063-1070.
33. Janelsins, M.C., Mastrangelo, M.A., Oddo, S., LaFerla, F.M., Federoff, H.J. and Bowers, W.J. (2005) Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J. Neuroinflammation, 2, 23.
34. Janelsins, M.C., Mastrangelo, M.A., Park, K.M., Sudol, K.L., Narrow, W.C., Oddo, S., LaFerla, F.M., Callahan, L.M., Federoff, H.J. and Bowers, W.J. (2008) Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Am. J. Pathol., 173, 1768-1782.
35. Pennanen, C., Kivipelto, M., Tuomainen, S., Hartikainen, P., Hanninen, T., Laakso, M.P., Hallikainen, M., Vanhanen, M., Nissinen, A., Helkala, E.L. et al. (2004) Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol. Aging, 25, 303-310.
36. Tili, E., Michaille, J.J., Cimino, A., Costinean, S., Dumitru, C.D., Adair, B., Fabbri, M., Alder, H., Liu, C.G., Calin, G.A. et al. (2007) Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-Stimulation and Their possible roles in regulating the response to endotoxin shock. J. Immunol., 15, 5082-5089.
37. Pogue, A.I., Cui, J.G., Li, Y.Y., Zhao, Y., Culicchia, F. and Lukiw, W.J. (2010) Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci. Lett., 476, 18-122.
38. Hebert, S.S. and De Strooper, B. (2009) Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci., 32, 199-206.
39. Delay, C. and Hebert, S.S. (2011) MicroRNAs and Alzheimer's disease mouse models: current insights and future research avenues. Int. J. Alzheimers Dis., 2011, 894938.
40. Tarassishin, L., Loudig, O., Bauman, A., Shafit-Zagardo, B., Suh, H.S. and Lee, S.C. (2011) Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*. Glia, 59, 1911-1922.
41. Ponomarev, E.D., Veremeyko, T. and Weiner, H.L. (2013) MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia, 61, 91-103.
42. Yao, R., Ma, Y.L., Liang, W., Li, H.H., Ma, Z.J., Yu, X. and Liao, Y.H. (2012) MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One, 7, e46082.
43. Yoshimura, A., Naka, T. and Kubo, M. (2007) SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol., 7, 454-465.
44. Baker, B.J., Akhtar, L.N. and Benveniste, E.N. (2009) SOCS1andSOCS3in the control of CNS immunity. Trends Immunol., 30, 392-400.
45. Ma, X., Becker Buscaglia, L.E., Barker, J.R. and Li, Y. (2011) MicroRNAs in NF-kappaB signaling. J. Mol. Cell Biol., 3, 159-166.
46. Jones, L., Holmans, P.A., Hamshere, M.L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R. et al. (2010) Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One, 5, e13950.
47. Holmans, P., Moskvina, V., Jones, L., Sharma, M., International Parkinson's Disease Genomics Consortium, Vedernikov, A., Buchel, F., Saad, M., Bras, J.M., Bettella, F. et al. (2013) Apathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease. Hum. Mol. Genet., 22, 1039-1049.
48. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J.S., Younkin, S. et al. (2013) TREM2 variants in Alzheimer's disease. N. Engl. J. Med., 368, 117-127.
49. Guerreiro, R.J., Santana, I., Bras, J.M., Santiago, B., Paiva, A. and Oliveira, C. (2007) Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener. Dis., 4, 406-412.
50. Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A., Holtzman, D.M., Jagust, W.J., Petersen, R.C. et al. (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7, 270-279.
51. Wyss-Coray, T. (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med., 12, 1005-1015.
52. Rivest, S. (2009) Regulation of innate immune responses in the brain. Nat. Rev. Immunol., 9, 429-439.
53. Krabbe, G., Halle, A., Matyash, V., Rinnenthal, J.L., Eom, G.D., Bernhardt, U., Miller, K.R., Prokop, S., Kettenmann, H. and Heppner, F.L. (2013) Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One, 8, e60921.
54. Varnum, M.M. and Ikezu, T. (2012) The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch. Immunol. Ther. Exp. (Warsz.), 60, 251-266.
55. Callizot, N., Combes, M., Steinschneider, R. and Poindron, P. (2013) Operational dissection of beta-amyloid cytopathic effects on cultured neurons. J. Neurosci. Res., 91, 706-716.
56. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. and LaFerla, F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron, 39, 409-421.
57. Rebeck, G.W., Hoe, H.S. and Moussa, C.E. (2010) Beta-amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss. J. Biol. Chem., 285, 7440-7446.
58. Takaoka, A. and Yanai, H. (2006) Interferon signalling network in innate defence. Cell Microbiol., 8, 907-922.
59. Khandelwal, P.J., Herman, A.M. and Moussa, C.E. (2011) Inflammation in the early stages of neurodegenerative pathology. J. Neuroimmunol., 238, 1-11.
60. Zaheer, S., Thangavel, R., Wu, Y., Khan, M.M., Kempuraj, D. and Zaheer, A. (2013) Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice. Neurochem. Res., 38, 218-225.
61. Qin, H., Wilson, C.A., Lee, S.J. and Benveniste, E.N. (2006) IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. FASEB J., 20, 985-987.
62. Costa, P.M., Cardoso, A.L., Mendonca, L.S., Serani, A., Custodia, C., Conceicao, M., Simoes, S., Moreira, J.N., Pereira de Almeida, L. and Pedroso de Lima, M.C. (2013) Tumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: A promising system for glioblastoma treatment. Mol. Ther. Nucleic Acids, 2, e100.
63. Worm, J., Stenvang, J., Petri, A., Frederiksen, K.S., Obad, S., Elmen, J., Hedtjarn, M., Straarup, E.M., Hansen, J.B. and Kauppinen, S. (2009) Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF. Nucleic Acids Res., 37, 5784-5792.
64. Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S. and Mallardo, M. (2008) Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res., 36, 6608-6619.
65. Guo, Q., Fu, W., Sopher, B.L., Miller, M.W., Ware, C.B., Martin, G.M. and Mattson, M.P. (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med., 5, 101-106.
66. Simoes, A.T., Goncalves, N., Koeppen, A., Deglon, N., Kugler, S., Duarte, C.B. and Pereira de Almeida, L. (2012) Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease. Brain, 135, 2428-2439.
67. Resende, R., Ferreiro, E., Pereira, C. and Resende de Oliveira, C. (2008) Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience, 155, 725-737.
68. Lu, J. and Tsourkas, A. (2009) Imaging individual microRNAs in single mammalian cells in situ. Nucleic Acids Res., 37, e100.